Tom Martin
@tombmt133
Associate Chief Hematology, Director- Blood and Marrow Transplant,
ID: 812851718014701568
25-12-2016 02:45:26
205 Tweet
2,2K Followers
152 Following
Just out: International Myeloma Working Group guidelines for bispecific antibodies myeloma. Limited time: Free copy link in the thread. The Lancet Oncology Paula Rodriguez-Otero Jonathan Kaufman, MD Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Yi Lin Tom Martin marivi mateos Ben Derman Monique Minnema et al thelancet.com/journals/lanon…
CONGRESS #EHA2024 | Thierry Facon Université de Lille presents findings of the phase III IMROZ study (NCT03319667), evaluating efficacy and safety of Isa-VRd vs VRd in transplant-ineligible pts with NDMM (N=446). The study met its primary endpoint: 60-mo PFS rate was 63.2% with Isa-VRd
Next generation CAR with novel binding domain! Deep and durable response in high risk patients! Look forward to getting this to our patients! MCW Cancer Center European Hematology Association #eha2024
Thomas Martin, MD (Tom Martin), of UCSF Helen Diller Family Comprehensive Cancer Ctr, tells us what he's looking forward to regarding the Society of Hematologic Oncology (SOHO) 2024 annual meeting! Hear what he has to say ➡️ buff.ly/3Sn2jhM
<24 hours to SOHO 24 Join us Wednesday 7:00AM - bright and early MGRS =>Dr Nelson, POEMS => Dr Dispenzieri, the latest in Frailty => Dr Mian Society of Hematologic Oncology (SOHO)
Soho24 - and Wednesday 6:15PM will have our first MM Poster Walk - 4 posters - Perseus update (NDMM-TE), Iber-VD -new data (NDMM- TI), DREAMM-7 update RRMM, Mezi- triplet RRMM plus many excellent posters to view!!!! C ya there Society of Hematologic Oncology (SOHO)